Thus, as expected, CD64 levels on PMN of PAD patients differed significantly compared to healthy controls also in the other experimental conditions, i.e., isolation and incubation with and without LPS (Figure S1). The gene discussed is FCGR1A; the disease is peripheral arterial disease.